GSK Planned Off-Label Pitch At Every OB-GYN, Families Say

By Alison Noon (June 27, 2018, 10:15 PM EDT) -- "Bombshell" depositions have allegedly revealed GlaxoSmithKline employed — but later fired — a small team of specialists to secure hedge fund money and deploy pharmaceutical sales representatives to ask every OB-GYN in the country to prescribe an anti-nausea drug off-label, attorneys for hundreds of families suing the company told a Massachusetts federal judge Wednesday.

The families were allowed to extend a Friday discovery deadline to pursue more information on what two former product managers allegedly described as a plan in the mid-2000s to get 33,000 doctors to consider prescribing the antiemetic Zofran to pregnant women who did not need the drug...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!